144 related articles for article (PubMed ID: 26519258)
1. Leveraging growth factor induced macropinocytosis for targeted treatment of lung cancer.
Iglesias R; Koria P
Med Oncol; 2015 Dec; 32(12):259. PubMed ID: 26519258
[TBL] [Abstract][Full Text] [Related]
2. Recombinant elastin-based nanoparticles for targeted gene therapy.
Monfort DA; Koria P
Gene Ther; 2017 Oct; 24(10):610-620. PubMed ID: 28681841
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice.
Devalliere J; Dooley K; Hu Y; Kelangi SS; Uygun BE; Yarmush ML
Biomaterials; 2017 Oct; 141():149-160. PubMed ID: 28688286
[TBL] [Abstract][Full Text] [Related]
4. Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration.
Johnson T; Koria P
BioDrugs; 2016 Apr; 30(2):117-27. PubMed ID: 26820997
[TBL] [Abstract][Full Text] [Related]
5. Multivalent Targeting Based Delivery of Therapeutic Peptide using AP1-ELP Carrier for Effective Cancer Therapy.
Sarangthem V; Kim Y; Singh TD; Seo BY; Cheon SH; Lee YJ; Lee BH; Park RW
Theranostics; 2016; 6(12):2235-2249. PubMed ID: 27924160
[TBL] [Abstract][Full Text] [Related]
6. Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides.
Bidwell GL; Davis AN; Raucher D
J Control Release; 2009 Apr; 135(1):2-10. PubMed ID: 19095020
[TBL] [Abstract][Full Text] [Related]
7. Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin.
Bidwell GL; Fokt I; Priebe W; Raucher D
Biochem Pharmacol; 2007 Mar; 73(5):620-31. PubMed ID: 17161827
[TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a fusion protein between thermally responsive elastin-like polypeptide and interleukin-1 receptor antagonist: sustained release of a local antiinflammatory therapeutic.
Shamji MF; Betre H; Kraus VB; Chen J; Chilkoti A; Pichika R; Masuda K; Setton LA
Arthritis Rheum; 2007 Nov; 56(11):3650-61. PubMed ID: 17968946
[TBL] [Abstract][Full Text] [Related]
9. Heparan sulfate proteoglycan modulates keratinocyte growth factor signaling through interaction with both ligand and receptor.
LaRochelle WJ; Sakaguchi K; Atabey N; Cheon HG; Takagi Y; Kinaia T; Day RM; Miki T; Burgess WH; Bottaro DP
Biochemistry; 1999 Feb; 38(6):1765-71. PubMed ID: 10026256
[TBL] [Abstract][Full Text] [Related]
10. Expression of keratinocyte growth factor/fibroblast growth factor-7 and its receptor in human lung cancer: correlation with tumour proliferative activity and patient prognosis.
Yamayoshi T; Nagayasu T; Matsumoto K; Abo T; Hishikawa Y; Koji T
J Pathol; 2004 Sep; 204(1):110-8. PubMed ID: 15307144
[TBL] [Abstract][Full Text] [Related]
11. Specific and non-specific KGF inhibition of KGF-induced breast cancer cell motility.
Zang XP; Nguyen TN; Pento JT
Anticancer Res; 2002; 22(5):2539-45. PubMed ID: 12529961
[TBL] [Abstract][Full Text] [Related]
12. Targeting of EGF-displayed protein nanoparticles with anticancer drugs.
Matsumoto R; Hara R; Andou T; Mie M; Kobatake E
J Biomed Mater Res B Appl Biomater; 2014 Nov; 102(8):1792-8. PubMed ID: 24700640
[TBL] [Abstract][Full Text] [Related]
13. Growth Factor Tethering to Protein Nanoparticles via Coiled-Coil Formation for Targeted Drug Delivery.
Assal Y; Mizuguchi Y; Mie M; Kobatake E
Bioconjug Chem; 2015 Aug; 26(8):1672-7. PubMed ID: 26079837
[TBL] [Abstract][Full Text] [Related]
14. Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications.
Ryu JS; Raucher D
Expert Opin Drug Deliv; 2015 Apr; 12(4):653-67. PubMed ID: 25350837
[TBL] [Abstract][Full Text] [Related]
15. Development of keratinocyte growth factor receptor tyrosine kinase inhibitors for the treatment of cancer.
Hackett J; Xiao Z; Zang XP; Lerner ML; Brackett DJ; Brueggemeier RW; Li PK; Pento JT
Anticancer Res; 2007; 27(6B):3801-6. PubMed ID: 18225535
[TBL] [Abstract][Full Text] [Related]
16. [Expression and action of keratinocyte growth factor, keratinocyte growth factor receptor on CaSki cell].
Lu L; Wang D; Hu LN; Chen B; Jia HJ; Li JK; Wang DF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):836-8. PubMed ID: 17953372
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery.
Massodi I; Bidwell GL; Raucher D
J Control Release; 2005 Nov; 108(2-3):396-408. PubMed ID: 16157413
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer.
Cho K; Ishiwata T; Uchida E; Nakazawa N; Korc M; Naito Z; Tajiri T
Am J Pathol; 2007 Jun; 170(6):1964-74. PubMed ID: 17525264
[TBL] [Abstract][Full Text] [Related]
19. Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide.
Raucher D; Massodi I; Bidwell GL
Expert Opin Drug Deliv; 2008 Mar; 5(3):353-69. PubMed ID: 18318656
[TBL] [Abstract][Full Text] [Related]
20. Heparin is essential for a single keratinocyte growth factor molecule to bind and form a complex with two molecules of the extracellular domain of its receptor.
Hsu YR; Nybo R; Sullivan JK; Costigan V; Spahr CS; Wong C; Jones M; Pentzer AG; Crouse JA; Pacifici RE; Lu HS; Morris CF; Philo JS
Biochemistry; 1999 Feb; 38(8):2523-34. PubMed ID: 10029547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
